Serum metabolomics study of the association between dairy intake and the anti-müllerian hormone annual decline rate

[11] Chenouri S(2020)Anti-Müllerian hormone and ovarian reserve: update on assessing ovarian function J Clin Endocrinol Metab 105 3361-733

[12] Solaymani-Dodaran M(2015)Functional metabolomics: from biomarker discovery to metabolome reprogramming Protein Cell 6 628-15

[13] Azizi F(2017)The role of metabolomics in determination of new dietary biomarkers Proc Nutr Soc 76 295-158

[14] de Kat AC(2020)Serum metabolomics study of women with different annual decline rates of anti-Müllerian hormone: an untargeted gas chromatography–mass spectrometry-based study Hum Reprod 36 721-300

[15] van der Schouw YT(2009)Prevention of non-communicable disease in a population in nutrition transition: Tehran Lipid and Glucose Study phase II Trials 10 1-166

[16] Eijkemans MJ(2018)Review of rationale, design, and initial findings: Tehran Lipid and Glucose Study Int J Endocrinol Metab. 16 150-1019

[17] Herber-Gast GC(2010)Reproducibility and relative validity of food group intake in a food frequency questionnaire developed for the Tehran Lipid and Glucose Study J Epidemiol 20 289-565

[18] Visser JA(1995)Controlling the false discovery rate: a practical and powerful approach to multiple testing J R Stat Soc Series B Stat Methodol 57 161-347

[19] Verschuren WM(2010)Premature menopause or early menopause: long-term health consequences Maturitas 65 1012-740

[20] Richardson M(2013)Age at menopause, reproductive life span, and type 2 diabetes risk: results from the EPIC-InterAct study Diabetes Care 36 556-1433

[11] Chenouri S(2020)Anti-Müllerian hormone and ovarian reserve: update on assessing ovarian function J Clin Endocrinol Metab 105 3361-733

[12] Solaymani-Dodaran M(2015)Functional metabolomics: from biomarker discovery to metabolome reprogramming Protein Cell 6 628-15

[13] Azizi F(2017)The role of metabolomics in determination of new dietary biomarkers Proc Nutr Soc 76 295-158

[14] de Kat AC(2020)Serum metabolomics study of women with different annual decline rates of anti-Müllerian hormone: an untargeted gas chromatography–mass spectrometry-based study Hum Reprod 36 721-300

[15] van der Schouw YT(2009)Prevention of non-communicable disease in a population in nutrition transition: Tehran Lipid and Glucose Study phase II Trials 10 1-166

[16] Eijkemans MJ(2018)Review of rationale, design, and initial findings: Tehran Lipid and Glucose Study Int J Endocrinol Metab. 16 150-1019

[17] Herber-Gast GC(2010)Reproducibility and relative validity of food group intake in a food frequency questionnaire developed for the Tehran Lipid and Glucose Study J Epidemiol 20 289-565

[18] Visser JA(1995)Controlling the false discovery rate: a practical and powerful approach to multiple testing J R Stat Soc Series B Stat Methodol 57 161-347

[19] Verschuren WM(2010)Premature menopause or early menopause: long-term health consequences Maturitas 65 1012-740

[20] Richardson M(2013)Age at menopause, reproductive life span, and type 2 diabetes risk: results from the EPIC-InterAct study Diabetes Care 36 556-1433